April 2025 Corporate Presentation
4/4
March 2025 Corporate Presentation
3/12
3/11
Unlocking ROCK2 inhibition in the CNS
3/11
3/11
Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)
3/11
Statement of Changes in Beneficial Ownership (Form 4)
3/4
Initial Statement of Beneficial Ownership (Form 3)
3/4
Statement of Changes in Beneficial Ownership (Form 4)
2/28
Statement of Changes in Beneficial Ownership (Form 4)
2/28